(NASDAQ: MDWD) Mediwound's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 43.47%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.48%.
Mediwound's earnings in 2025 is -$20,604,000.On average, 8 Wall Street analysts forecast MDWD's earnings for 2025 to be -$27,441,713, with the lowest MDWD earnings forecast at -$28,396,910, and the highest MDWD earnings forecast at -$24,771,009. On average, 8 Wall Street analysts forecast MDWD's earnings for 2026 to be -$31,059,921, with the lowest MDWD earnings forecast at -$39,579,764, and the highest MDWD earnings forecast at -$26,117,259.
In 2027, MDWD is forecast to generate -$28,614,874 in earnings, with the lowest earnings forecast at -$34,302,462 and the highest earnings forecast at -$20,866,882.